BPC-157 + TB-500 Blend
Research-grade BPC-157 + TB-500 Blend, lyophilized powder, >99% HPLC purity. Third-party tested with a certificate of analysis per lot.
| Purity | >99% (HPLC) |
|---|
| Form | Lyophilized powder |
|---|
| Sizes | 10 mg / 10 mg |
|---|
Certificate of Analysis for BPC-157 + TB-500 Blend
Research reference
This preparation contains two independently characterized compounds. BPC-157 is a synthetic pentadecapeptide, sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, molecular weight approximately 1419.55 Da, first described in 1993; it has not been approved for use by the FDA or other regulatory authorities. Thymosin beta-4 is a 43-amino-acid polypeptide and the principal G-actin sequestering peptide in mammalian tissue; TB-500 corresponds to its active region. Research use only. Not for human consumption.
Literature
Related compounds: BPC-157 · TB-500 Fragment
All products are sold strictly for laboratory and research use only. Not for human or animal consumption, ingestion, injection, or diagnostic use. Not intended to diagnose, treat, cure, or prevent any disease.
